Pancreatic Cancer Research

ResearcherRutgers New Jersey Medical SchoolActive in the last 2 years

Patrick L. Quinn

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4133-2768; OpenAlex author ID A5091019582. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 3 papers · 2026: 5 papers

Papers 10

  1. Global Perspectives on Radiotherapy Utilization for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/s12029-026-01600-0↗
  2. Fragmented Care for Pancreatic Cancer Patients at a High-Volume Surgical Center. Co-author DOI 10.1016/j.jss.2026.03.035↗
  3. Medical and Surgical Oncologist Collaboration and Long-Term Outcomes Among Patients With Pancreatic Cancer. Co-author DOI 10.1016/j.jss.2026.06.023↗
  4. Time Toxicity and End-of-Life Treatment of Metastatic Pancreatic Cancer. Co-author DOI 10.1200/op-26-00413↗
  5. Simultaneous resection of pancreatic cancer and liver metastases following total neoadjuvant therapy: A case series and analysis of the National Cancer Databas… First author DOI 10.14701/ahbps.25-209↗
  6. Factors impacting informed decision-making for patients with pancreatic cancer: a qualitative study. Co-author DOI 10.1007/s00520-025-09878-9↗
  7. Shared-decision making in pancreatic cancer: A scoping review. Co-author DOI 10.1016/j.pec.2025.108828↗
  8. Surgical Second Opinion for Pancreatic Cancer Patients. Co-author DOI 10.1097/xcs.0000000000001213↗
  9. Staging CT and Diagnostic Laparoscopy With Cytology Prior to the Treatment of Pancreatic Adenocarcinoma: A Case Series. Co-author DOI 10.7759/cureus.31883↗
  10. Design of an immunohistochemistry biomarker panel for diagnosis of pancreatic adenocarcinoma. First author DOI 10.1016/j.pan.2019.08.007↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Aslam M. Ejaz · 8 shared papers, 2025–2026 · strength 2.71
  2. Jordan M. Cloyd · 4 shared papers, 2025–2026 · strength 1.16
  3. McKenzie L. Schaefer · 3 shared papers, 2026 · strength 1.08
  4. Timothy Michael Pawlik · 2 shared papers, 2026 · strength 0.62
  5. Mary E. Dillhoff · 2 shared papers, 2026 · strength 0.62
  6. Bradley Norman Reames · 1 shared paper, 2026 · strength 0.32
  7. Ziyi Zhou · 1 shared paper, 2026 · strength 0.32
  8. Eric David Miller · 1 shared paper, 2026 · strength 0.32
  9. Alison Gregorian · 1 shared paper, 2026 · strength 0.32
  10. Amol Kumar Narang · 1 shared paper, 2026 · strength 0.32
  11. Ravi J. Chokshi · 2 shared papers, 2019–2022 · strength 0.29
  12. Ashish Manne · 1 shared paper, 2026 · strength 0.26
  13. Anne M. Noonan · 1 shared paper, 2026 · strength 0.26
  14. Laith I. Abushahin · 1 shared paper, 2026 · strength 0.26
  15. Shafia Rahman · 1 shared paper, 2026 · strength 0.26
  16. J. Madison Hyer · 1 shared paper, 2025 · strength 0.26
  17. Neal S. Panse · 1 shared paper, 2022 · strength 0.19
  18. Simran Arjani · 1 shared paper, 2022 · strength 0.19
  19. Atuhani S. Burnett · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.